Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.
Assadi-Porter FM, Reiland H, Sabatini M, Lorenzini L, Carnicelli V, Rogowski M, Selen Alpergin ES, Tonelli M, Ghelardoni S, Saba A, Zucchi R, Chiellini G. Assadi-Porter FM, et al. Among authors: saba a. Int J Mol Sci. 2018 May 22;19(5):1535. doi: 10.3390/ijms19051535. Int J Mol Sci. 2018. PMID: 29786646 Free PMC article.
Tissue distribution and cardiac metabolism of 3-iodothyronamine.
Saba A, Chiellini G, Frascarelli S, Marchini M, Ghelardoni S, Raffaelli A, Tonacchera M, Vitti P, Scanlan TS, Zucchi R. Saba A, et al. Endocrinology. 2010 Oct;151(10):5063-73. doi: 10.1210/en.2010-0491. Epub 2010 Aug 25. Endocrinology. 2010. PMID: 20739399
3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells.
Agretti P, De Marco G, Russo L, Saba A, Raffaelli A, Marchini M, Chiellini G, Grasso L, Pinchera A, Vitti P, Scanlan TS, Zucchi R, Tonacchera M. Agretti P, et al. Among authors: saba a. J Mol Endocrinol. 2011 Jul 12;47(1):23-32. doi: 10.1530/JME-10-0168. Print 2011 Aug. J Mol Endocrinol. 2011. PMID: 21511808
Detection of 3-iodothyronamine in human patients: a preliminary study.
Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, Scanlan TS, Iervasi G, Zucchi R. Galli E, et al. Among authors: saba a. J Clin Endocrinol Metab. 2012 Jan;97(1):E69-74. doi: 10.1210/jc.2011-1115. Epub 2011 Oct 26. J Clin Endocrinol Metab. 2012. PMID: 22031514
3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice.
Manni ME, De Siena G, Saba A, Marchini M, Dicembrini I, Bigagli E, Cinci L, Lodovici M, Chiellini G, Zucchi R, Raimondi L. Manni ME, et al. Among authors: saba a. Br J Pharmacol. 2012 May;166(2):650-8. doi: 10.1111/j.1476-5381.2011.01823.x. Br J Pharmacol. 2012. PMID: 22225569 Free PMC article.
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold.
Manni ME, De Siena G, Saba A, Marchini M, Landucci E, Gerace E, Zazzeri M, Musilli C, Pellegrini-Giampietro D, Matucci R, Zucchi R, Raimondi L. Manni ME, et al. Among authors: saba a. Br J Pharmacol. 2013 Jan;168(2):354-62. doi: 10.1111/j.1476-5381.2012.02137.x. Br J Pharmacol. 2013. PMID: 22889145 Free PMC article.
321 results